| In millions, except per share items | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 | Jun-30-14 | Jun-30-13 | Jun-30-12 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Revenues: |
| Technology licensing and related services | | 0.6 | 0.2 | 0.4 | 0.1 | | 0.6 | |
| Other | | 0.9 | | 5.6 | 15.4 | | 0.0 | |
| Total revenues [+] | 0.0 | 1.5 | 0.2 | 6.0 | 15.5 | 17.5 | 0.6 | 3.1 |
| Products | | | | 4.8 | 15.1 | 14.9 | | 2.1 |
| License and services | | | | 0.3 | | | | |
| Other | | | | | | | | 0.1 |
| Revenue growth [+] | -100.0% | 898.0% | -97.5% | -61.4% | -11.4% | 2923.7% | -81.1% | -69.9% |
| Technology licensing and related services | | 306.0% | -63.5% | 177.9% | | | | |
| SES China | | | | -63.7% | -12.2% | 218737.5% | | |
| Cost of goods sold | 0.4 | 0.4 | 0.1 | 7.2 | 19.7 | 17.4 | 3.1 | 5.6 |
| Gross profit | -0.4 | 1.1 | 0.0 | -1.2 | -4.2 | 0.1 | -2.5 | -2.6 |
| Gross margin | | 72.6% | 6.0% | -20.4% | -27.0% | 0.8% | -429.7% | -84.4% |
| Selling, general and administrative [+] | 5.4 | 6.5 | 8.6 | 8.5 | 9.0 | 10.0 | 13.6 | 13.2 |
| General and administrative | 5.4 | 6.5 | 8.6 | 8.5 | 9.0 | 10.0 | 13.6 | 13.2 |
| Equity in earnings | -0.2 | -0.7 | -0.3 | -0.2 | | 0.0 | -1.4 | -1.9 |
| Other operating expenses | -1.9 | 1.1 | 1.7 | 3.3 | 2.6 | 1.5 | | |
| EBITDA [+] | -4.1 | -7.2 | -10.7 | -13.3 | -15.8 | -11.4 | -17.5 | -17.7 |
| EBITDA growth | -42.7% | -32.4% | -19.9% | -15.6% | 38.7% | -34.9% | -1.1% | 31.1% |
| EBITDA margin | | -478.0% | -7057.0% | -221.9% | -101.5% | -64.9% | -3015.4% | -576.8% |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.6 | 1.4 | 2.1 | 2.1 | 2.3 |
| EBITA | -4.1 | -7.2 | -10.7 | -13.9 | -17.1 | -13.5 | -19.5 | -19.9 |
| EBITA margin | | -479.0% | -7066.9% | -232.7% | -110.4% | -76.8% | -3373.7% | -650.8% |
| Amortization of intangibles | 0.3 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| EBIT [+] | -4.4 | -7.2 | -10.7 | -14.2 | -17.4 | -13.7 | -19.8 | -20.1 |
| EBIT growth | -39.4% | -32.5% | -24.3% | -18.4% | 27.2% | -30.9% | -2.0% | 25.2% |
| EBIT margin | | -480.4% | -7100.7% | -236.5% | -111.9% | -78.0% | -3411.2% | -658.0% |
| Non-recurring items [+] | 6.9 | 3.6 | 17.7 | 8.6 | 20.9 | | | |
| Asset impairment | 5.0 | 3.5 | 17.7 | 8.6 | 20.9 | | | |
| Interest expense, net [+] | 1.3 | 0.8 | 0.0 | 0.4 | 0.3 | 0.3 | 0.3 | 0.5 |
| Interest expense | 1.3 | 0.9 | | 0.4 | 0.4 | 0.4 | 0.3 | 0.6 |
| Interest income | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 |
| Other income (expense), net [+] | 1.8 | 2.0 | -0.1 | -0.4 | 0.0 | 0.0 | 0.1 | 20.6 |
| Unrealized gain/loss on derivatives | 1.9 | 2.1 | | | | | | |
| Gain (loss) on foreign currency transactions | -0.1 | 0.1 | -0.1 | -0.4 | 0.0 | 0.0 | | -0.5 |
| Other | | 1.7 | | | | 0.7 | | |
| Pre-tax income | -10.7 | -9.7 | -28.5 | -23.6 | -38.5 | -14.0 | -19.9 | 0.0 |
| Income taxes | 0.0 | -0.1 | -2.0 | -0.5 | -0.7 | 0.2 | 0.0 | 0.0 |
| Tax rate | 0.0% | 1.3% | 6.9% | 2.2% | 1.7% | | 0.0% | |
| Minority interest | 0.0 | 0.0 | 0.0 | -0.5 | -0.7 | 0.2 | 0.0 | 0.2 |
| Earnings from continuing ops | -10.7 | -9.6 | -56.9 | -23.1 | -37.9 | -14.2 | -19.9 | -20.2 |
| Earnings from discontinued ops | | | 1.9 | | | | | |
| Net income | -10.7 | -9.6 | -55.0 | -23.1 | -37.9 | -14.2 | -19.9 | -20.2 |
| Net margin | | -637.3% | -36425.8% | -385.1% | -244.1% | -81.4% | -3440.9% | -661.3% |
| |
| Basic EPS [+] | ($7.74) | ($7.01) | ($5.23) | ($0.27) | ($0.50) | ($0.22) | ($0.33) | ($0.40) |
| Growth | 10.4% | 34.1% | 1865.7% | -46.9% | 132.3% | -34.9% | -16.6% | 22.2% |
| Diluted EPS [+] | ($7.74) | ($7.01) | ($5.23) | ($0.27) | ($0.50) | ($0.22) | ($0.33) | ($0.40) |
| Growth | 10.4% | 34.1% | 1865.7% | -46.9% | 132.3% | -34.9% | -16.6% | 22.2% |
| |
| Shares outstanding (basic) [+] | 1.4 | 1.4 | 10.9 | 86.8 | 75.7 | 66.1 | 60.2 | 51.0 |
| Growth | 1.0% | -87.4% | -87.4% | 14.6% | 14.5% | 9.9% | 17.9% | 5.0% |
| Shares outstanding (diluted) [+] | 1.4 | 1.4 | 10.9 | 86.8 | 75.7 | 66.1 | 60.2 | 51.0 |
| Growth | 1.0% | -87.4% | -87.4% | 14.6% | 14.5% | 9.9% | 17.9% | 5.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |